Perceived cognitive function in breast cancer survivors: Evaluating relationships with objective cognitive performance and other symptoms using the functional assessment of cancer therapy - Cognitive function instrument

Journal of Pain and Symptom Management

Volumn 49, Issue 4, 2015, Pages 697-706

  Von Ah, Diane ^a   Tallman, Eileen F ^b  

^a INDIANA UNIVERSITY SCHOOL OF NURSING   (United States)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

breast cancer survivor; Cognitive impairment; neuropsychological assessment; symptoms

Indexed keywords

ANTINEOPLASTIC AGENT; AROMATASE INHIBITOR; TAMOXIFEN;

ADULT; AGED; ANXIETY DISORDER; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVOR; CAUCASIAN; CLINICAL ASSESSMENT TOOL; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; DEPRESSION; EXECUTIVE FUNCTION; FATIGUE; FEMALE; FUNCTIONAL ASSESSMENT; HUMAN; MAJOR CLINICAL STUDY; MEMORY DISORDER; MULTIMODALITY CANCER THERAPY; NEUROPSYCHOLOGICAL TEST; PERCEIVED COGNITIVE IMPAIRMENT; PERCEPTION; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SELF REPORT; SLEEP DISORDER; SLEEP QUALITY; VERBAL MEMORY; BREAST NEOPLASMS; COGNITION DISORDERS; COMPLICATION; MIDDLE AGED; PSYCHOLOGY; SURVIVOR;

BREAST NEOPLASMS; COGNITION; COGNITION DISORDERS; FEMALE; HUMANS; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PERCEPTION; QUESTIONNAIRES; SURVIVORS;

EID: 84925969915     PISSN: 08853924     EISSN: 18736513     Source Type: Journal    
DOI: 10.1016/j.jpainsymman.2014.08.012     Document Type: Article

References (81)

1. N. Boykoff, M. Moieni, and S.K. Subramanian Confronting chemobrain: an in-depth look at survivors' reports of impact on work, social networks, and health care response J Cancer Surviv 3 2009 223 232
2. F. Munir, J. Burrows, J. Yarker, K. Kalawsky, and M. Bain Women's perceptions of chemotherapy-induced cognitive side affects on work ability: a focus group J Clin Nurs 19 2010 1362 1370
3. J.S. Myers Chemotherapy-related cognitive impairment: the breast cancer experience Oncol Nurs Forum 39 2012 E31 E40
4. D. Von Ah, B. Habermann, J. Carpenter, and B.L. Schneider Impact of perceived cognitive impairment in breast cancer survivors Eur J Oncol Nurs 17 2013 236 241
5. C.M. Bender, F.S. Ergyn, M.Q. Rosenzweig, S.M. Cohen, and S.M. Sereika Symptom clusters in breast cancer across 3 phases of the disease Cancer Nurs 28 2005 219 225
6. J.S. Myers Cancer- and chemotherapy-related cognitive changes: the patient experience Semin Oncol Nurs 29 2013 300 307
7. T. Mitchell, and P. Turton "Chemobrain": concentration and memory effects in people receiving chemotherapy - a descriptive phenomenological study Eur J Cancer Care 20 2011 1 10
8. M.J. Pullens, J. De Vries, and J.A. Roukema Subjective cognitive dysfunction in breast cancer patients: a systematic review Psychooncology 19 2010 1127 1138
9. T. Mitchell The social and emotional toll of chemotherapy patients' perspectives Eur J Cancer Care 16 2007 39 47
10. H.S. Jim, K.M. Phillips, and S. Chait Meta-analysis of cognitive functioning in breast cancer survivors previously treated with standard-dose chemotherapy J Clin Oncol 30 2012 3578 3587
11. A. Stewart, C. Bielajew, B. Collins, M. Parkinson, and E. Tomiak A meta-analysis of the neuropsychological effects of adjuvant chemotherapy treatment in women treated for breast cancer Clin Neuropsychol 20 2006 76 89
12. C.E. Jansen, C. Miakowski, M. Dodd, G. Dowling, and J. Kramer A meta analysis of studies of the effects of cancer chemotherapy on various domains of cognitive function Cancer 104 2005 222 233
13. M.G. Falleti, A. Sanfilippo, P. Maruff, L. Weih, and K.A. Phillips The nature and severity of cognitive impairment associated with adjuvant chemotherapy in women with breast cancer: a meta-analysis of the current literature Brain Cogn 59 2005 60 70
14. J. Lai, Z. Butt, and L. Wagner Evaluating the dimensionality of perceived cognitive function J Pain Symptom Manage 37 2009 982 995
15. C. Jansen Cognitive changes associated with cancer and cancer therapy: patient assessment and education Semin Oncol Nurs 4 2013 270 279
16. L.A. Ouimet, A. Stewart, B. Collins, D. Schindler, and C. Bielajew Investigation of neuropsychological screen for chemo-fog Oncol Rev 5 2011 205 213
17. A.D. Hutchison, J.R. Hosking, G. Kichenadasse, J.K. Mattiske, and C. Wilson Objective and subjective cognitive impairment following chemotherapy for cancer: a systematic review Cancer Treat Rev 38 2012 926 934
18. S.B. Schagen, F.S. van Dam, and M.J. Muller Cognitive deficits after postoperative adjuvant chemotherapy for breast cancer Cancer 85 1999 640 650
19. A. Cull, C. Hay, and S.B. Love What do cancer patients mean when they complain of concentration and memory problems? Br J Cancer 74 1996 1674 1679
20. V. Jenkins, V. Shilling, L. Fallowfield, A. Howell, and S. Hutton Does hormone therapy for the treatment of breast cancer have a detrimental effect on memory and cognition? A pilot study Psychooncology 13 2004 61 66
21. V. Jenkins, V. Shilling, and G. Deutsch A 3-year prospective study of the effects of adjuvant treatments on cognition in women with early stage breast cancer Br J Cancer 94 2006 828 834
22. A. Paganini-Hill, and L.J. Clark Preliminary assessment of cognitive function in breast cancer patients treated with tamoxifen Breast Cancer Res Treat 64 2000 165 176
23. R.J. Ferguson, B.C. McDonald, A.J. Saykin, and T.A. Ahles Brain structure and function differences in monozygotic twins: possible effects of breast cancer chemotherapy J Clin Oncol 25 2007 3866 3870
24. S. Deprez, F. Amant, and R. Yigit Chemotherapy-induced structural changes in cerebral white matter and its correlation with impaired cognitive functioning in breast cancer patients Hum Brain Mapp 32 2011 480 493
25. L. Wagner, J. Sweet, and Z. Butt Measuring patient self-reported cognitive function: development of the functional assessment of cancer therapy - cognitive function instrument J Support Oncol 7 2009 W32 W39
26. S.R. Jacobs, P.B. Jacobsen, M. Booth-Jones, L.I. Wagner, and C. Anasetti Evaluation of the functional assessment of cancer therapy cognitive scale with hematopoietic stem cell transplant patients J Pain Symptom Manage 33 2007 13 23
27. L. Wagner, J.S. Lai, D. Cella, J. Sweet, and S. Forrestal Chemotherapy-related cognitive deficits: development of the FACT-Cog instrument Ann Behav Med 27 Suppl 10 2004
28. S. Deprez, F. Amant, and A. Smeets Longitudinal assessment of chemotherapy induced structural changes in cerebral white matter and its correlation with impaired cognitive function J Clin Oncol 30 2012 274 281
29. F. Joly, M. Lange, and O. Rigal French version of the Functional Assessment of Cancer Therapy-Cognitive Function (FACT-Cog) version 3 Support Care Cancer 20 2012 3297 3305
30. J.S. Lai, L.I. Wagner, P.B. Jacobsen, and D. Cella Self-reported cognitive concerns and abilities: two sides of one coin? Psychooncology 2014 [Epub ahead of print]
31. D. Von Ah, J.S. Carpenter, and A. Saykin Advanced cognitive training for breast cancer survivors: a randomized controlled trial Breast Cancer Res Treat 135 2012 799 809
32. J.B. Jobe, D.M. Smith, and K. Ball ACTIVE: a cognitive intervention trial to promote independence in older adults Control Clin Trials 22 2001 453 479
33. A. Rey L'examen psychologique dans les cas d'encephalopathie traumatique Arch Psychol 28 1941 286 340
34. G.A. Stallings, C. Boake, and M. Sherer Comparison of the California Verbal Learning Test and the Rey Auditory Verbal Learning Test in head-injured patients J Clin Exp Neuropsychol 17 1995 706 712
35. S. Magalhes, L.F. Malloy-Diniz, and A.C. Hamdan Validity convergent and reliability test-retest of the Rey Auditory Verbal Learning Test Clin Neuropsychiatry 9 2012 129 137
36. D. Von Ah, K. Harvison, and P. Monahan Cognitive function in breast cancer survivors compared to healthy age- and education-matched women Clin Neuropsychol 23 2009 661 674
37. R.G. Knight, J. McMahon, M. Skeaff, and T.J. Green Reliable change index scores for persons over the age of 65 tested on alternate forms of the Rey AVLT Arch Clin Neuropsychol 22 2007 513 518
38. G.M. Geffen, P. Butterworth, and L.B. Geffen Test-retest reliability of a new form of the auditory verbal learning test (AVLT) Arch Clin Neuropsychol 9 1994 303 316
39. D. Loring, and R.M. Bauer Testing the limits: cautions and concerns regarding the new Wechsler IQ and memory scales Neurology 74 2010 685 690
40. National Institutes of Health. NIH toolbox auditory verbal learning test (Rey). 2013. Available at: http://www.nihtoolbox.org/WhatAndWhy/Cognition/EpisodicMemory/Pages/NIH-Toolbox-Auditor-Verbal-Learning-Test-(Rey).aspx. Accessed June 1, 2013.
41. B. Wilson, J. Cockburn, and A. Baddeley The rivermead behavioral memory test 1985 Thames Valley Test, Co. and National Rehabilitation Services England and Michigan
42. M.D. Lezak, D.B. Howieson, and D.W. Loring Neuropsycholgical assessment 4th ed. 2004 Oxford Unviersity Press New York
43. C. de Wall, B.A. Wilson, and A.D. Baddeley The extended Rivermead Behavioural Memory Test: a measure of everyday memory performance in normal adults Memory 2 1994 149 166
44. B.A. Wilson The assessment, evaluation and rehabilitation of everyday memory problems 2014 Psychology Press New York
45. K.K. Paraska, and C.M. Bender Cognitive dysfunction following adjuvant chemotherapy for breast cancer: two case studies Oncol Nurs Forum 30 2003 473 478
46. A. Smith Symbol Digit Modalities Test 1982 Western Psychological Services Los Angeles
47. R.J. Sbordone, R.E. Saul, and A.D. Purisch Neuropsychology for psychologists, health care professionals and attorneys 3rd ed. 2007 CRC Press Boca Raton, FL
48. L.I. Berrigan, J.D. Fisk, and L.A. Walker Reliability of regression-based normative data for the oral symbol digit modalities test: an evaluation of demographic influences, construct validity, and impairment classification rates in multiple sclerosis samples Clin Neuropsychol 28 2014 281 299
49. A.L. Benton, and K.D. Hamsher Multilingual aphasia examination 1989 AJA Associates Iowa City, IA
50. R.M. Ruff, R.H. Light, S.B. Parker, and H.S. Levin Benton controlled oral word association test: reliability and updated norms Arch Clin Neuropsychol 11 1996 329 338
51. R.M. Ruff, R.H. Light, S.B. Parker, and H.S. Levin The psychological construct of word fluency Brain Lang 57 1997 394 405
52. M.M. Weissman, D. Sholomskas, M. Pottenger, B.A. Prusoff, and B.Z. Locke Assessing depressive symptoms in five psychiatric populations: a validation study Am J Epidemiol 106 1977 203 214
53. L.S. Radloff The CES-d scale Appl Psychol Meas 1 1977 385 401
54. C.P. van Wilgen, P.U. Dijkstra, R.W. Stewart, A.W. Ranchor, and J.L. Roodenburg Measuring somatic symptoms with the CES-D to assess depression in cancer patients after treatment: comparison among patients with oral/oropharyngeal, gynecological, colorectal, and breast cancer Psychosomatics 47 2006 465 470
55. R.J. Ferguson, B.C. McDonald, and M.A. Rocque Cognitve-behavioral management of chemotherapy-related cognitive change Psychooncology 16 2007 772 777
56. S.B. Yellen, D.F. Cella, K. Webster, C. Blendowski, and E. Kaplan Measuring fatigue and other anemia-related symptoms with the Functional Assessment of Cancer Therapy (FACT) measurement system J Pain Symptom Manage 13 1997 63 74
57. F. Graziano, R. Bisonni, and V. Catalano Potential role of levocarnitine supplementation for the treatment of chemotherapy-induced fatigue in non-anaemic cancer patients Br J Cancer 86 2002 1854 1857
58. A. Shafqat, L.H. Einhorn, and N. Hanna Screening studies for fatigue and laboratory correlates in cancer patients undergoing treatment Ann Oncol 16 2005 1545 1550
59. B.M. Pinto, C. Rabin, S. Abdow, and G.D. Papandonatos A pilot study on disseminating physical activity promotion among cancer survivors: a brief report Psychooncology 17 2008 517 521
60. N. Tchen, H.G. Juffs, and F.P. Downie Cognitive function, fatigue, and menopausal symptoms in women receiving adjuvant chemotherapy for breast cancer J Clin Oncol 21 2003 4175 4183
61. C.D. Spielberger, R.I. Gorsuch, and R.G. Lushene Manual for the state-trait anxiety inventory 1971 Consulting Press Palo Alto, CA
62. L.M. McCracken, and G.L. Iverson Predicting complaints of impaired cognitive functioning in patients with chronic pain J Pain Symptom Manage 21 2001 392 396
63. C.D. Spielberger Manual for the state-trait anxiety inventory (Form Y) 1983 Consulting Psychologists Press Palo Alto, CA
64. G. ÖZalp, R. Sarioglu, G. Tuncel, K. Aslan, and N. Kadiogullari Preoperative emotional states in patients with breast cancer and postoperative pain Acta Anaesthesiol Scand 47 2003 26 29
65. D.J. Buysse, C.F. Reynolds, T.H. Monk, S.R. Berman, and D.J. Kupfer The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research Psychiatry Res 28 1989 193 213
66. J.S. Carpenter, and M.A. Andrykowski Psychometric evaluation of the Pittsburgh sleep quality Index J Psychosom Res 45 1998 5 13
67. B.V. Fortner, E.J. Stephanski, S.C. Wang, S. Kasprowicz, and H.H. Durrence Sleep and quality of life in breast cancer patients J Pain Symptom Manage 24 2002 471 480
68. C.L. Uchiyama, L.F. D'Elia, and A.M. Dellinger Alternate forms of the auditory-verbal learning test: issues of test comparability, longitudinal reliability and moderating demographic variables Arch Clin Neuropsychol 10 1995 133 145
69. C.M. Bender, and B.D. Thelen Cancer and cognitive changes: the complexity of the problem Semin Oncol Nurs 29 2013 232 237
70. G. LoBiondo-Wood, C.G. Brown, and M.T. Knobf Priorities for oncology nursing: the 2013 national survey Oncol Nurs Forum 42 2014 67 76
71. J. Vardy, K. Wong, and Q.L. Yi Assessing cognitive function in cancer patients Support Care Cancer 14 2006 1111 1118
72. C.M. Bender, M.L. Pacella, and S.M. Sereika What do perceived cognitive problems reflect? J Support Oncol 6 2008 238 242
73. G. Kilbiger, K.L. Kirsh, J.R. Wall, and S.D. Passik My mind is as clear as it used to be: a pilot study illustrating the difficulties of employing a single-item subjective screen to detect cognitive impairment in outpaients with cancer J Pain Symptom Manage 26 2003 705 715
74. M. Poppelreuter, J. Weis, and A.K. Kulz Cognitive dysfunction and subjective complaints of cancer patients. a cross-sectional study in a cancer rehabilitation centre Eur J Cancer 40 2004 43 49
75. V. Shilling, and V. Jenkins Self-reported cognitive problems in women receiving adjuvant therapy for breast cancer Eur J Oncol Nurs 11 2007 6 15
76. K. Hermelink, H. Kuchenhoff, and M. Untch Two different sides of 'chemobrain': determinants and nondeterminants of self-perceived cognitive dysfunction in a prospective, randomized, multicenter study Psychooncology 19 2010 1321 1328
77. A. Mehnert, A. Scherwath, and L. Schirmer The association between neuropsychological impairment, self-perceived cognitive deficits, fatigue, and quality of life in breast cancer survivors following standard adjuvant versus high-dose chemotherapy Patient Educ Couns 66 2007 108 118
78. F.P. Downie, H.G. Mar Fan, N. Houede-Tchen, Q. Yi, and I.F. Tannock Cognitive function, fatigue, and menopausal symptoms in breast cancer patients receiving adjuvant chemotherapy: evaluation with patient interview after formal assessment Psychooncology 15 2006 921 930
79. S.A. Reid-Arndt, C. Hsieh, and M.C. Perry Neuropsychological functioning and quality of life during the first year after completing chemotherapy for breast cancer Psychooncology 19 2010 535 544
80. J. Weis, M. Poppelreuter, and H.H. Bartsch Cognitive deficits as long-term side-effects of adjuvant therapy in breast cancer patients: 'subjective' complaints and 'objective' neuropsychological test results Psychooncology 18 2009 775 782
81. M. Poppelreuter, J. Weis, and H.H. Bartsch Effects of specific neuropsychological training programs for breast cancer patients after adjuvant chemotherapy J Psychosoc Oncol 27 2009 274 296